Efficacy and safety of novel topical pigment-correcting regimen with biweekly diamond tip microdermabrasion procedures on facial hyperpigmentation

J Cosmet Dermatol. 2024 May;23(5):1726-1733. doi: 10.1111/jocd.16192. Epub 2024 Jan 30.

Abstract

Background: Facial hyperpigmentation can negatively affect an individual's emotional and psychosocial well-being.

Aims: Assess safety and tolerability of a combination of microdermabrasion (DG) procedures using a novel brightening pro-infusion serum (EC-DG) with a targeted at-home treatment regimen in subjects with mild to severe facial hyperpigmentation, including melasma, post-inflammatory hyperpigmentation, and dark spots.

Patients/methods: This 12-week, open-label study enrolled 18 subjects (Fitzpatrick skin types I-IV) who underwent 6 in-office DG procedures with EC-DG (one procedure administered biweekly), along with daily topical application of a brightening treatment serum and dark spot cream. End points included change from baseline across multiple skin quality attributes and the Melasma Area and Severity Index (MASI), self-assessment questionnaires, and tolerability assessments.

Results: The combination treatment was well tolerated and resulted in significant (p ≤ 0.05) improvements from baseline in radiance, tactile roughness, and moisturization/hydration immediately after the first treatment, in MASI score at day 3, and in overall hyperpigmentation at week 4. Most (94.1%) subjects were satisfied with treatment.

Conclusions: DG procedures using EC-DG combined with a targeted at-home skincare regimen are effective and tolerable for treating facial hyperpigmentation across a broad range of skin types.

Keywords: combination treatment; hyperpigmentation; lotus sprout extract; pigmentation disorders; skin care.

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Combined Modality Therapy / adverse effects
  • Combined Modality Therapy / methods
  • Dermabrasion* / adverse effects
  • Dermabrasion* / instrumentation
  • Dermabrasion* / methods
  • Face
  • Facial Dermatoses / drug therapy
  • Facial Dermatoses / therapy
  • Female
  • Humans
  • Hyperpigmentation* / drug therapy
  • Hyperpigmentation* / etiology
  • Male
  • Melanosis / diagnosis
  • Melanosis / drug therapy
  • Melanosis / therapy
  • Middle Aged
  • Severity of Illness Index*
  • Skin Lightening Preparations / administration & dosage
  • Skin Lightening Preparations / adverse effects
  • Treatment Outcome
  • Young Adult

Substances

  • Skin Lightening Preparations